Global HIV Drugs Market 2015-2019 - New Study Released

HIV is a type of retrovirus that causes infection in human beings. AIDS is a life-threatening disease caused by this virus. In this disease certain white blood cells (lymphocytes) are destroyed, resulting in the loss of the body's ability to protect itself against infections. The major route of transmission of HIV infection is unprotected sex, contaminated needle, breast milk, and infected blood. HIV attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. The anti-retroviral therapy is used to treat the patient and help the immune system fight the infection. This is mainly used to keep the level of the HIV low in the body.

Full Report Details at
- http://www.fastmr.com/prod/1060726_global_hiv_drugs_20152019.aspx?afid=301

Technavio's analysts forecast the global HIV drugs market to grow at a CAGR of 4.52% over the period 2014-2019.

Covered in this report
This report covers the present scenario and the growth prospects of the global HIV drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various generic and branded drugs and the expected launch of drug candidates used in the treatment of HIV infection.

Based on the class of drugs, the market is segmented as follows:

* Multi-class combination products
* Nucleoside reverse transcriptase inhibitors
* Non-nucleoside reverse transcriptase inhibitors
* Protease inhibitors
* Fusion inhibitors
* Entry inhibitors - CCR5 co-receptor antagonist
* HIV integrase strand transfer inhibitors

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

Technavio's report, Global HIV Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions

* Americas
* APAC
* EMEA

Key vendors

* Bristol-Myers Squibb
* Gilead Sciences
* GlaxoSmithKline
* Johnson & Johnson
* Merck

Other prominent vendors

* AbbVie
* AstraZeneca
* Boehringer Ingelheim
* Cipla
* Daiichi Sankyo
* Emcure
* F. Hoffmann-La Roche
* Hetero Drugs
* Mylan
* Pfizer
* Shionogi
* Teva Pharmaceutical Industries

Market driver

* Inflow of funds

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- HIV-1 Infection Global Clinical Trials Review, H2, 2014
- HIV-2 Infection Global Clinical Trials Review, H2, 2014
- HIV / AIDS - Pipeline Review, H1 2015
- EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2023
- Global Fibromyalgia Drugs Market 2015-2019